United States Apixaban Market Report 2016

Publisher Name :
Date: 07-Oct-2016
No. of pages: 117
Inquire Before Buying

Notes:

Sales, means the sales volume of Apixaban

Revenue, means the sales value of Apixaban

This report studies sales (consumption) of Apixaban in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Apixaban in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Apixaban Market Report 2016

Table of Contents
United States Apixaban Market Report 2016
1 Apixaban Overview
1.1 Product Overview and Scope of Apixaban
1.2 Classification of Apixaban
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Apixaban
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Apixaban (2011-2021)
1.4.1 United States Apixaban Sales and Growth Rate (2011-2021)
1.4.2 United States Apixaban Revenue and Growth Rate (2011-2021)
2 United States Apixaban Competition by Manufacturers
2.1 United States Apixaban Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Apixaban Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Apixaban Average Price by Manufactures (2015 and 2016)
2.4 Apixaban Market Competitive Situation and Trends
2.4.1 Apixaban Market Concentration Rate
2.4.2 Apixaban Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Apixaban Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Apixaban Sales and Market Share by Type (2011-2016)
3.2 United States Apixaban Revenue and Market Share by Type (2011-2016)
3.3 United States Apixaban Price by Type (2011-2016)
3.4 United States Apixaban Sales Growth Rate by Type (2011-2016)
4 United States Apixaban Sales (Volume) by Application (2011-2016)
4.1 United States Apixaban Sales and Market Share by Application (2011-2016)
4.2 United States Apixaban Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Apixaban Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Apixaban Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Apixaban Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Apixaban Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Apixaban Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Apixaban Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Apixaban Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Apixaban Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Apixaban Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Apixaban Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Apixaban Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Apixaban Manufacturing Cost Analysis
6.1 Apixaban Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Apixaban
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Apixaban Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Apixaban Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Apixaban Market Forecast (2016-2021)
10.1 United States Apixaban Sales, Revenue Forecast (2016-2021)
10.2 United States Apixaban Sales Forecast by Type (2016-2021)
10.3 United States Apixaban Sales Forecast by Application (2016-2021)
10.4 Apixaban Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Apixaban
Table Classification of Apixaban
Figure United States Sales Market Share of Apixaban by Type in 2015
Table Application of Apixaban
Figure United States Sales Market Share of Apixaban by Application in 2015
Figure United States Apixaban Sales and Growth Rate (2011-2021)
Figure United States Apixaban Revenue and Growth Rate (2011-2021)
Table United States Apixaban Sales of Key Manufacturers (2015 and 2016)
Table United States Apixaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Apixaban Sales Share by Manufacturers
Figure 2016 Apixaban Sales Share by Manufacturers
Table United States Apixaban Revenue by Manufacturers (2015 and 2016)
Table United States Apixaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Apixaban Revenue Share by Manufacturers
Table 2016 United States Apixaban Revenue Share by Manufacturers
Table United States Market Apixaban Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Apixaban Average Price of Key Manufacturers in 2015
Figure Apixaban Market Share of Top 3 Manufacturers
Figure Apixaban Market Share of Top 5 Manufacturers
Table United States Apixaban Sales by Type (2011-2016)
Table United States Apixaban Sales Share by Type (2011-2016)
Figure United States Apixaban Sales Market Share by Type in 2015
Table United States Apixaban Revenue and Market Share by Type (2011-2016)
Table United States Apixaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Apixaban by Type (2011-2016)
Table United States Apixaban Price by Type (2011-2016)
Figure United States Apixaban Sales Growth Rate by Type (2011-2016)
Table United States Apixaban Sales by Application (2011-2016)
Table United States Apixaban Sales Market Share by Application (2011-2016)
Figure United States Apixaban Sales Market Share by Application in 2015
Table United States Apixaban Sales Growth Rate by Application (2011-2016)
Figure United States Apixaban Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Apixaban Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Apixaban Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Apixaban Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Apixaban Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Apixaban Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Apixaban Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Apixaban Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Apixaban Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Apixaban Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Apixaban Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Apixaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Apixaban Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Apixaban
Figure Manufacturing Process Analysis of Apixaban
Figure Apixaban Industrial Chain Analysis
Table Raw Materials Sources of Apixaban Major Manufacturers in 2015
Table Major Buyers of Apixaban
Table Distributors/Traders List
Figure United States Apixaban Production and Growth Rate Forecast (2016-2021)
Figure United States Apixaban Revenue and Growth Rate Forecast (2016-2021)
Table United States Apixaban Production Forecast by Type (2016-2021)
Table United States Apixaban Consumption Forecast by Application (2016-2021)
  • Asia-Pacific Veterinary Chemistry Analyzers Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the Asia-Pacific Veterinary Chemistry Analyzers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Veterinary Chemistry Analyzers for these regions, from 2012 to 2022 (forecast), including - China - Japan......
  • Asia-Pacific Vaccine Refrigerators Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the Asia-Pacific Vaccine Refrigerators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Vaccine Refrigerators for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Kor......
  • Asia-Pacific Ultrasonic Scalpel Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the Asia-Pacific Ultrasonic Scalpel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Ultrasonic Scalpel for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • Asia-Pacific Oxygen Therapy Equipments Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the Asia-Pacific Oxygen Therapy Equipments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Oxygen Therapy Equipments for these regions, from 2012 to 2022 (forecast), including - China - Japan - S......
  • Asia-Pacific MI Neurosurgery Devices Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 111
    In this report, the Asia-Pacific MI Neurosurgery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of MI Neurosurgery Devices for these regions, from 2012 to 2022 (forecast), including - China - Japan - South......
  • Asia-Pacific Held Pulse Oximeters Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 119
    In this report, the Asia-Pacific Held Pulse Oximeters market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Held Pulse Oximeters for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • EMEA (Europe, Middle East and Africa) Microwave Therapeutic Instruments Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 112
    In this report, the EMEA Microwave Therapeutic Instruments market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Microwave Therapeutic Instruments for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK......
  • EMEA (Europe, Middle East and Africa) Microwave Ablators Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the EMEA Microwave Ablators market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Microwave Ablators for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • EMEA (Europe, Middle East and Africa) Medical Cannula Market Report 2017
    Published: 27-Jun-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the EMEA Medical Cannula market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Medical Cannula for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs